Having raised $142 million for its debut fund, Genesis Capital joins a select group of Australian mid-market GPs with blind pools. The firm believes a singular focus on healthcare was a key selling point
Few Australia-focused managers have closed debut middle-market funds in recent years. Potentia Capital and Genesis Capital are exceptions to the rule, and both happen to be sector specialists, focusing...
US-based Liberty City Ventures has led a USD 359m round for Hong Kong blockchain media company Animoca Brands at a pre-money valuation of USD 5bn, more than double its valuation in October.
Harmay, a China-based omnichannel beauty products retailer, has raised USD 200m across Series C and D rounds.
Novotech, an Asia-based clinical trials specialist controlled by TPG Capital, has secured USD 760m in new equity and debt financing at a post-deal valuation of approximately USD 3bn.
Quadrant Private Equity has sold Journey Beyond, an Australia-based experiential tourism business, to US-based Hornblower Group, which is best known for offering cruise and sightseeing packages.